Titan Biotech Ltd — Dividend/Bonus, 30-05-2025: Corp. Action

Titan Biotech has announced a board meeting to approve the financial results for the quarter and half-year ended March 31, 2025, with both standalone and consolidated audited results receiving unmodified opinions from the statutory auditors. The Board has proposed a dividend of Rs. 2.00 per equity share for the financial year 2024-25, subject to shareholder approval. Key appointments include Mr. Amit Anand as Secretarial Auditor for five years, M/s Sanjay Kumar Garg & Associates as Cost Auditor for FY 2025-26, PGM & Associates as Internal Auditor for two years, and Mr. Pankaj Kumar Gupta as Scrutinizer for the upcoming Annual General Meeting. These appointments aim to strengthen the company’s compliance and audit processes, reflecting a focus on robust governance.